Patents by Inventor Mark Budde

Mark Budde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150329868
    Abstract: The present invention relates to a continuous production system for producing carbon-containing compounds, comprising a genetically modified photosynthetic microorganism, such as a Cyanobacterium, that contains one or more mutations or deletions in a glycogen biosynthesis or storage pathway. The system and methods provided herein facilitate the production of carbon-containing compounds under reduced growth conditions, including biofuels, lipids, and other specialty chemicals, such as fatty acids, alkanes, alkenes, wax esters, and triglycerides.
    Type: Application
    Filed: January 31, 2013
    Publication date: November 19, 2015
    Inventors: Jason W. Hickman, Cameron Miller, Mark Budde, James Roberts, Fred Cross, Kimberly Marie Kotovic, Paul Warrener, Brett K. Kaiser, Michael Carleton
  • Publication number: 20120282353
    Abstract: The present invention generally relates to the modulation of hypoxia-inducible factor (HIF) using the compounds and methods disclosed herein. These compounds and methods can be applied to the prevention, pretreatment, and/or treatment of conditions or states associated with HIF, such as hypoxia- and ischemia-related conditions and the induction of stasis.
    Type: Application
    Filed: March 26, 2012
    Publication date: November 8, 2012
    Applicant: Fred Hutchinson Cancer Research Center
    Inventors: Mark B. Roth, Mark Budde
  • Patent number: 7844459
    Abstract: The words of the target vocabulary are composed of segments, which have one or more phonemes, whereby the segments are derived from a training text that is independent from the target vocabulary. The training text can be an arbitrary generic text.
    Type: Grant
    Filed: April 24, 2001
    Date of Patent: November 30, 2010
    Assignee: Siemens Aktiengesellschaft
    Inventors: Mark Budde, Tobias Schneider
  • Publication number: 20090011051
    Abstract: The present invention generally relates to the modulation of hypoxia-inducible factor (HIF) using the compounds and methods disclosed herein. These compounds and methods can be applied to the prevention, pretreatment, and/or treatment of conditions or states associated with HIF, such as hypoxia- and ischemia-related conditions and the induction of stasis.
    Type: Application
    Filed: September 28, 2007
    Publication date: January 8, 2009
    Inventors: Mark B. Roth, Mark Budde
  • Publication number: 20030120490
    Abstract: The words of the target vocabulary are composed of segments, which have one or more phonemes, whereby the segments are derived from a training text that is independent from the target vocabulary. The training text can be an arbitrary generic text.
    Type: Application
    Filed: November 12, 2002
    Publication date: June 26, 2003
    Inventors: Mark Budde, Tobias Schneider